AU572162B2 - Hepatitis b vaccine - Google Patents

Hepatitis b vaccine

Info

Publication number
AU572162B2
AU572162B2 AU29993/84A AU2999384A AU572162B2 AU 572162 B2 AU572162 B2 AU 572162B2 AU 29993/84 A AU29993/84 A AU 29993/84A AU 2999384 A AU2999384 A AU 2999384A AU 572162 B2 AU572162 B2 AU 572162B2
Authority
AU
Australia
Prior art keywords
hepatitis
vaccine
inactivated
stabilizer
surface antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU29993/84A
Other languages
English (en)
Other versions
AU2999384A (en
Inventor
Yoshimitsu Ishihara
Tetsuo Kawahara
Kyosuke Mizuno
Nobuya Ohtomo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14848502&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU572162(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Publication of AU2999384A publication Critical patent/AU2999384A/en
Application granted granted Critical
Publication of AU572162B2 publication Critical patent/AU572162B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AU29993/84A 1983-07-05 1984-06-28 Hepatitis b vaccine Ceased AU572162B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58122945A JPS6013718A (ja) 1983-07-05 1983-07-05 Ｂ型肝炎ワクチン
JP58-122945 1983-07-05

Publications (2)

Publication Number Publication Date
AU2999384A AU2999384A (en) 1985-01-10
AU572162B2 true AU572162B2 (en) 1988-05-05

Family

ID=14848502

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29993/84A Ceased AU572162B2 (en) 1983-07-05 1984-06-28 Hepatitis b vaccine

Country Status (7)

Country Link
EP (1) EP0130619B1 (enExample)
JP (1) JPS6013718A (enExample)
KR (1) KR910005888B1 (enExample)
AT (1) ATE41309T1 (enExample)
AU (1) AU572162B2 (enExample)
CA (1) CA1237076A (enExample)
DE (1) DE3477139D1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60193925A (ja) * 1984-03-13 1985-10-02 Chemo Sero Therapeut Res Inst 凍結乾燥製剤化ワクチン
EP0294071A3 (en) * 1987-06-03 1990-08-01 Merck & Co. Inc. Hepatitis b vaccines made with pre-formed aluminum hydroxide gels, and processes thereof
JP3626996B2 (ja) * 1992-05-23 2005-03-09 グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム Ｂ型肝炎表面抗原および他の抗原からなる複合ワクチン
AU4932493A (en) * 1992-09-25 1994-04-26 Dynagen, Inc. An immunobooster for delayed release of immunogen
US6051238A (en) * 1996-12-20 2000-04-18 Merck & Co., Inc. Stabilizers for lyophilized mumps vaccines
US6290967B1 (en) * 1996-12-20 2001-09-18 Merck & Co., Inc. Stabilizers for lyophilized vaccines
NZ552576A (en) * 2000-06-08 2008-06-30 Powderject Vaccines Inc Salt adjuvant-containing gel-forming free flowing compositions in a powder form for transdermal delivery from a needless syringe
UA79735C2 (uk) 2000-08-10 2007-07-25 Глаксосмітклайн Байолоджікалз С.А. Очищення антигенів вірусу гепатиту b (hbv) для використання у вакцинах
WO2002101412A2 (en) 2001-06-08 2002-12-19 Powderject Vaccines, Inc. Spray freeze-dried compositions
KR20030025480A (ko) * 2001-09-21 2003-03-29 보령제약 주식회사 약독화 수두 생바이러스 백신용 무단백질 안정화제
US20060228369A1 (en) * 2005-04-11 2006-10-12 Program For Appropriate Technology In Health Stabilization and preservation of temperature-sensitive vaccines
AU2006299310A1 (en) 2005-10-04 2007-04-12 Alk-Abello A/S Solid vaccine formulation
AU2007317847B2 (en) 2006-11-07 2013-10-31 Sanofi Pasteur Biologics, Llc Stabilization of vaccines by lyophilization
TW201043267A (en) * 2009-03-19 2010-12-16 Intervet Int Bv In situ constituting a vaccine for administration to a predetermined herd of animals
DK2552410T3 (en) * 2010-03-31 2019-02-18 Stabilitech Biopharma Ltd PROCEDURE FOR THE CONSERVATION OF ALUNADUVANCES AND VACCINES WITH ALUNADUVANCES
EP2898890B1 (en) 2010-03-31 2019-08-21 Stabilitech Biopharma Ltd Stabilisation of viral particles
CA2795047C (en) 2010-03-31 2019-04-09 Stabilitech Ltd. Stabilised liquid formulations
AU2012272788B2 (en) 2011-06-24 2016-10-20 Merck Sharp & Dohme Llc HPV vaccine formulations comprising aluminum adjuvant and methods of producing same
WO2013012022A1 (ja) 2011-07-19 2013-01-24 中外製薬株式会社 アルギニンアミドまたはその類似化合物を含む安定なタンパク質含有製剤
GB201117233D0 (en) 2011-10-05 2011-11-16 Stabilitech Ltd Stabilisation of polypeptides
JP5931449B2 (ja) * 2012-01-11 2016-06-08 日東電工株式会社 医薬組成物及びその製造方法
GB201406569D0 (en) 2014-04-11 2014-05-28 Stabilitech Ltd Vaccine compositions
EP3444004B1 (en) * 2016-04-15 2020-12-02 FUJIFILM Corporation Microneedle array
GB2562241B (en) 2017-05-08 2022-04-06 Stabilitech Biopharma Ltd Vaccine compositions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3674864A (en) * 1966-12-16 1972-07-04 Erba Carlo Spa Process for stabilizing preparations of interfering viruses
GB1442564A (en) * 1973-12-28 1976-07-14 Green Cross Corp Process for preparing inactivated hb ag vaccine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2879202A (en) * 1954-11-05 1959-03-24 American Cyanamid Co Stabilization of live viral vaccines by hexahydric alcohols
DE1617350C3 (de) * 1967-06-22 1979-09-06 Behringwerke Ag, 3550 Marburg Verfahren zur Inaktivierung von biologischem Material
US3636191A (en) * 1969-10-08 1972-01-18 Cancer Res Inst Vaccine against viral hepatitis and process

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3674864A (en) * 1966-12-16 1972-07-04 Erba Carlo Spa Process for stabilizing preparations of interfering viruses
GB1442564A (en) * 1973-12-28 1976-07-14 Green Cross Corp Process for preparing inactivated hb ag vaccine

Also Published As

Publication number Publication date
EP0130619A3 (en) 1985-04-10
EP0130619B1 (en) 1989-03-15
JPH0437806B2 (enExample) 1992-06-22
EP0130619A2 (en) 1985-01-09
CA1237076A (en) 1988-05-24
KR850002277A (ko) 1985-05-10
ATE41309T1 (de) 1989-04-15
JPS6013718A (ja) 1985-01-24
DE3477139D1 (en) 1989-04-20
KR910005888B1 (ko) 1991-08-06
AU2999384A (en) 1985-01-10

Similar Documents

Publication Publication Date Title
AU572162B2 (en) Hepatitis b vaccine
AU576223B2 (en) Lyophilized hepatitis b vaccine
EP0339667A3 (en) Hepatitis a,b,-combined adjuvanted vaccine
RU94046145A (ru) Комбинированные вакцины, содержащие поверхностный антиген гепатита в и другие антигены, способ их получения, способ предупреждения инфекций гепатита в
RU94042386A (ru) Вакцина против гепатита, содержащая 3-0-дезацилированный монофосфорил-липида, применение антигена гепатита для получения препарата для лечения гепатита, способ лечения гепатита
PT78132B (en) Process for the preparation of lyophilized adsorbed polyvalent vaccines
HU9400741D0 (en) Immunoreactive hepatitis c virus polypeptide compositions
AU1093088A (en) Hepatitis b virus surface antigens and hybrid antigens containing them
MY110086A (en) Herpes simplex virus vaccines comrpising glycoprotein d and 3d-mpl
GR3007158T3 (enExample)
AU589331B2 (en) Improved method for the isolation and purification of hepatitis B surface antigen using polysorbate
AU3254184A (en) Herpes simplex vaccine
AU2521792A (en) Chicken anaemia agent vaccine
CA2135630A1 (en) Hiv protein epitopes immunologically homologous to hla
AU2403188A (en) Infectious bovine rhinotracheitis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
AU2888089A (en) Infectious bovine rhinotracheitis virus insertion mutants, vaccines containing same, and methods for the production and use of same
IE873268L (en) Conjugate vaccine
NZ228232A (en) Live combined vaccine comprising at least one live infectious bronchitis virus and at least one other virus infectious to poultry
DE2962921D1 (en) Feline infectious peritonitis vaccine and process for its preparation
AU554859B2 (en) Polymerized albumin vaccine
AU1668788A (en) Method of vaccination for hepatitis b virus
EP0668356A3 (en) Recombinant infectious bovine rhinotracheitis virus mutant, methods for the production of same, and vaccines containing the same
AU2713488A (en) Process for manufacturing antigens, vaccines and sera to combat bacterial or viral diseases and composition for implementing said process
AU614735C (en) Canine distemper virus vaccine
ZA936199B (en) Recombinant antigens and vaccines of bovine ephemeral fever virus